ESA-SRB-AOTA 2019

Denosumab-associated spontaneous vertebral fractures: A case-series (#600)

Madhuni Herath 1 , Phillip Wong 1 2 3 , Frances Milat 1 2 3
  1. Department of Endocrinology, Monash Health, Melbourne, VIC
  2. Department of Medicine, Monash University, Melbourne, VIC
  3. Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Melbourne
Publish consent withheld
  1. 1. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 2009;361(8):756-65.
  2. 2. Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B. Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report. The Journal of Clinical Endocrinology & Metabolism. 2016;102(2):354-8.